Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The purpose of the CARDAMON study is: • To determine the efficacy of the triple regimen Carfilzomib, Cyclophosphamide and Dexamethasone (CarCyDex) as induction in untreated patients with symptomatic multiple myeloma (MM) who are candidates for autologous stem cell transplantation (ASCT). • To evaluate the benefit (progression free survival at 2 years) of upfront ASCT in patients achieving at least a partial response (PR) to induction with CarCyDex.
Critère d'inclusion
- Multiple myeloma